Single-Specialty Clinics

India’s interest in single-specialty clinic chains is not new. Eye care, diagnostics, dental, IVF, maternity, and other focused healthcare formats have existed for decades. What has changed is the ambition behind the model.

Earlier specialty healthcare businesses were often built around a trusted doctor, institution, or diagnostic reputation. The current wave is trying to make the clinic itself repeatable: a standardized unit with defined capex, staffing, service mix, patient journey, local demand engine, and payback period.

The key question is no longer just whether a specialty can support a chain. It is whether the clinic box can be copied across catchments without depending on founder hustle, one exceptional doctor, or unusually favorable local demand.

A clinic box includes six layers. The visible part is the clinic: interiors, equipment, location, and branding. The valuable part is the operating system underneath it.

A good clinic P&L is only the starting point

A mature clinic can look very attractive on paper. The full article’s mature-clinic model assumes ₹40 lakh monthly revenue, around 950 monthly visits or sessions, and clinic-level EBITDA of ₹10.6 lakh, or 26.5% of revenue.

But this represents a mature clinic where utilization, local awareness, repeat usage, and operating rhythm are already working.

The mature clinic P&L is useful because it shows the ceiling case: what a clinic can look like once utilization, local trust, referrals, and operating rhythm are already in place. But it should not be mistaken for the base case. A new clinic will usually have the same fixed costs from day one — rent, clinician salaries, equipment, staff, software — while revenue builds slowly.

The real test, therefore, is not whether one mature clinic can reach 25–30% clinic-level EBITDA. The test is whether the company can repeatedly move new clinics from low utilization to mature utilization without CAC, rent, doctor underutilization, or central overhead eating away the economics.

Scale is where the model gets tested

The problem is that this mature-clinic P&L is a ceiling, not the base case. The model starts to break when a chain expands.

The investor lens: repeatability over optics

For investors, the core lens is repeatability. Mature clinics should show healthy EBITDA after realistic rent, clinician salaries, and CAC. New clinics should ramp in a pattern that resembles older clinics. Trust should gradually move from individual doctors to the brand. Clinical quality should be governable centrally.

Most importantly, central overhead should make the model more repeatable, not merely consume clinic-level profits.

We share more about our learnings from founder conversations in the full article here:
https://ishanpendse.com/writings/single-specialty-clinics